Cognitive impairment in Chinese neuromyelitis optica

Multiple Sclerosis

Volumn 21, Issue 14, 2015, Pages 1839-1846

  Zhang, N ^a   Li, Y J ^a   Fu, Y ^a   Shao, J H ^a   Luo, L L ^a   Yang, L ^a   Shi, F D ^a,b   Liu, Y ^a,c,d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

brain volume; cognitive impairment; MACFIMS; MRI; Neuromyelitis optica; white matter abnormality

Indexed keywords

AQUAPORIN 4 ANTIBODY; AQUAPORIN 4;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAIN SIZE; CHINESE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; MALE; MYELOOPTIC NEUROPATHY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOLOGICAL PARAMETERS; WHITE MATTER LESION; CHINA; COGNITION DISORDERS; COMPLICATION; MEMORY DISORDERS; MIDDLE AGED; NEUROMYELITIS OPTICA; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; BRIEF VISUOSPATIAL MEMORY TEST; CALIFORNIA VERBAL LEARNING TEST; COGNITIVE FUNCTION TEST; CONTROLLED ORAL WORD ASSOCIATION TEST; DISEASE DURATION; EXECUTIVE FUNCTION TEST; HANDEDNESS; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; PACED AUDITORY SERIAL ADDITION TEST; SYMBOL DIGIT MODALITIES TEST; WISCONSIN CARD SORTING TEST;

ADULT; CHINA; COGNITION DISORDERS; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROMYELITIS OPTICA; PSYCHOMOTOR PERFORMANCE;

EID: 84948125236     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515576982     Document Type: Article

References (35)

1. Matthews L, Marasco R, Jenkinson M, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurol 2013; 80: 1330-1337.
2. Rao SM, Leo GJ, Bernardin L, et al. Cognitivedysfunction in multiple sclerosis. IFrequency, patterns, and prediction. Neurol 1991; 41: 685-691.
3. Patti F, Amato MP, Trojano M, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009; 15: 779-788.
4. Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12: 549-558.
5. Nilsson P, Rorsman I, Larsson EM, et al. Cognitive dysfunction 24-31 years after isolated optic neuritis. Mult Scler 2008; 14: 913-918.
6. Blanc F, Zephir H, Lebrun C, et al. Cognitive functions in neuromyelitis optica. Arch Neurol. 2008; 65: 84-88.
7. He D, Wu Q, Chen X, et al. Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse. Brain Cogn 2011; 77: 80-88.
8. Vanotti S, Cores EV, Eizaguirre B, et al. Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis. Arq Neuropsiquiatr 2013; 71.
9. Saji E, Arakawa M, Yanagawa K, et al. Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol 2013; 73: 65-76.
10. Dusankova JB, Kalincik T, Havrdova E, et al. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Clin Neuropsychol 2012; 26: 1186-1200.
11. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurol 2006; 66: 1485-1489.
12. Yang CS, Yang L, Li T, et al. Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica. Neurol 2013; 81: 710-713.
13. Yang CS, Zhang DQ, Wang JH, et al. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China. CNS Neurosci Ther 2014; 20: 32-39.
14. Yu J, Li J, Huang X,. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study. BMC Psychiatry 2012; 12: 156.
15. Gronwall DM,. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 1977; 44: 367-373.
16. Smith A,. Symbol digit modalities test: Manual. Los Angeles, CA: Western Psychological Services, 1982.
17. Delis DC, Freeland J, Kramer JH, et al. Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol 1988; 56: 123-130.
18. Benedict RHB,. Brief visuospatial memory test-Revised professional manual. Odessa, FL: Psychological Assessment Resources, 1997.
19. Benton AL, Sivan AB, Hamsher K, et al. Contributions to neuropsychological assessment. New York, NY: Oxford University Press, 1994.
20. Kempler D, Teng EL, Dick M, et al. The effects of age, education, and ethnicity on verbal fluency. J Int Neuropsychol Soc 1998; 4: 531-538.
21. Mok VC, Wong A, Yim P, et al. The validity and reliability of chinese frontal assessment battery in evaluating executive dysfunction among Chinese patients with small subcortical infarct. Alzheimer Dis Assoc Disord 2004; 18: 68-74.
22. Yu X,. Norm manual of MCCB in China, 1st edn. Beijing: Peking University Medical Press, 2014 (in Chinese).
23. Zhao PX, Zhang N, Cheng Y,. Cognitive impairment in patients with lacunar infarction: risk factors and features. Int J Cerebrovascular Dis 2014; 22: 28-32 (in Chinese).
24. Thornton AE, Raz N, Tucke KA,. Memory in multiple sclerosis: contextual encoding deficits. J Int Neuropsychol Soc 2002; 8: 395-409.
25. Pichiecchio A, Tavazzi E, Poloni G, et al. Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler 2012; 18: 817-824.
26. Chan KH, Tse CT, Chung CP, et al. Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol 2011; 68: 1432-1439.
27. Liu Y, Xie T, He Y, et al. Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica. Eur Radiol 2014; 24: 2334-2343.
28. Liu Y, Duan Y, He Y, et al. Altered topological organization of white matter structural networks in patients with neuromyelitis optica. PLoS One 2012; 7: e48846. Doi: 10.1371/journal.pone.0048846.
29. Liu Y, Duan Y, He Y, et al. A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations. Mult Scler 2012; 18: 1013-1021.
30. Sanchez-Catasus CA, Cabrera-Gomez J, AlmaguerMelian W, et al. Brain tissue volumes and perfusion change with the number of optic neuritis attacks in relapsing neuromyelitis optica: a voxel-based correlation study. PLoS One 2013; 8: e66271. Doi: 10.1371/journal.pone.0066271.
31. Liu Y, Liang P, Duan Y, et al. Abnormal baseline brain activity in patients with neuromyelitis optica: a resting-state fMRI study. Eur J Radiol 2011; 80: 407-411.
32. Sumowski JF, Rocca MA, Leavitt VM, et al. Brain reserve and cognitive reserve in multiple sclerosis: what you've got and how you use it. Neurol 2013; 80: 2186-2193.
33. Schneider EB, Sur S, Raymont V, et al. Functional recovery after moderate/severe traumatic brain injury: a role for cognitive reserve? Neurol 2014; 82: 1636-1642.
34. Lo RY, Jagust WJ,. Effect of cognitive reserve markers on Alzheimer pathologic progression. Alzheimer Dis Assoc Disord 2013; 27: 343-350.
35. Mortamais M, Portet F, Brickman AM, et al. Education modulates the impact of white matter lesions on the risk of mild cognitive impairment and dementia. Am J Geriatr Psychiatry 2014; 22: 1336-1345.